Canada Pension Plan Investment Board Sage Therapeutics, Inc. Transaction History

Canada Pension Plan Investment Board

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$37.27 - $46.57 $2.36 Million - $2.95 Million	63,300 New	63,300 $2.66 Million
Q1 2021 May 17, 2021	SELL	$70.65 - $96.76 $600,525 - $822,460	-8,500 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$58.41 - $89.06 $375,342 - $572,299	-6,426 Reduced 43.05%	8,500 $735,000
Q3 2020 Nov 12, 2020	SELL	$41.13 - $62.45 $216,055 - $328,049	-5,253 Reduced 26.03%	14,926 $912,000
Q2 2020 Aug 14, 2020	BUY	$25.95 - $43.15 $523,645 - $870,723	20,179 New	20,179 $839,000
Q4 2017 Feb 14, 2018	SELL	$60.72 - $167.34 $48,576 - $133,872	-800 Closed	0 $0
Q3 2017 Oct 30, 2017	SELL	$61.4 - $88.52 $85,960 - $123,928	-1,400 Reduced 63.64%	800 $50,000
Q2 2017 Jan 31, 2018	BUY	N/A	2,200	2,200 $175,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.